The #1 Community for Investors
Results 101 - 110 of 12671 : Previous 7 8 9 10 11 12 13 14 15 Next
Polypore's 2011 Points to Promise
A strong start to 2011 is offset by a weak second half.
It was a good year for the industry but not for investors.
3 Stock-Moving Binary Events to Watch in 2012
A look at what's coming up in biotech.
A Bad Year for the 6,300% Miracle
Human Genome Sciences falls from grace.
What to Look For With Seattle Genetics in 2012
The launch of its new drug Adcetris will be key.
Too Early for a New Biotech Orphan?
Alexion makes a big purchase.
The Stock I'm Most Likely to Sell
Mounting negatives cast serious shadows on First Solar. Is it time to sell?
What to Look For From Keryx and Aeterna Zentaris in 2012
The future is uncertain for these pharmaceutical companies.
Results 101 - 110 of 12671 : Previous 7 8 9 10 11 12 13 14 15 Next
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK